Cargando…
Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pu...
Autores principales: | Hwang, Kyu-won, Woo, Ok Hee, Yong, Hwan Seok, Shin, Bong Kyung, Shim, Jae Jeong, Kang, Eun-Young |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Radiological Society
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627222/ https://www.ncbi.nlm.nih.gov/pubmed/18385565 http://dx.doi.org/10.3348/kjr.2008.9.2.175 |
Ejemplares similares
-
Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
por: Moon, Ji Yoon, et al.
Publicado: (2013) -
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis
por: Cho, Yu Kyung, et al.
Publicado: (2022) -
Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007) -
Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013) -
Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
por: Cho, Yu Kyung, et al.
Publicado: (2020)